Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

Alex Carll, assistant professor in the UofL Department of Physiology, front, with Matthew Nystoriak, associate professor of medicine. (UofL Photo)
News | Atrial Fibrillation
UofL Researchers Discover E-Cigarettes Cause Cardiac Arrhythmias

October 26, 2022 —  A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute  ...

Home October 26, 2022
Home
Donald Baril, MD, a Leading Vascular Surgeon in the Smidt Heart Institute, Named Director of the Vascular Surgery Fellowship Program
News | Cardiovascular Surgery
Vascular Surgeon to Lead, Train Fellows

October 24, 2022 The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as ...

Home October 24, 2022
Home
Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps.
News | Cardiogenic Shock
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure

October 21, 2022 —  Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post ...

Home October 21, 2022
Home
The American Heart Association to enable a wide range of research with real-time data from acute care hospitals
News | Cardiogenic Shock
New Data Registry Collects Evidence in Cardiogenic Shock Patients

October 20, 2022 — Cardiogenic shock—a life threatening condition when a person’s heart can’t pump enough blood to meet ...

Home October 20, 2022
Home
After dedicating the last 28 years to building one of the world’s leading cardiovascular centers, Dr. Fuster will continue to advance the clinical care, research, and innovative training at Mount Sinai Heart. Image courtesy of Mount Sinai Health System
News | Cardiovascular Business
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart

October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named ...

Home October 19, 2022
Home
For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.
News | Heart Failure
Cardiovascular Disease Risks the Same in Both Sexes

October 19, 2022 — For men and women, the risk factors for cardiovascular disease are largely the same, an extensive ...

Home October 19, 2022
Home
Abiomed’s 14 Fr Impella Low Profile Sheath and dilator set.
News | Heart Valve Technology
U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath

October 18, 2022 —  The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for its ...

Home October 18, 2022
Home
People with cardiovascular disease still have a high burden of risk factors for severe COVID
News | Coronavirus (COVID-19)
Smoking, Diabetes and Obesity - Not Preexisting Heart Disease - Bigger Risk of COVID-19 Death, Study Finds

October 17, 2022 —  A national study suggests that risk factors for cardiovascular disease, such as age, smoking and ...

Home October 17, 2022
Home
Low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill. McMaster University
News | Pharmaceuticals
The Polypill Could Avoid Millions of Premature Deaths, Heart Attacks and Strokes Every Year, Say Leading Cardiology Experts

October 17, 2022 —  Global Health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs ...

Home October 17, 2022
Home
Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP testinG, of Heart Failure therapies) study, announced the premature termination of the trial.
News | Cardiovascular Clinical Studies
STRONG-HF Study in Patients Admitted for Acute Heart Failure (HF) Terminated Early for Superior Efficacy

October 14, 2022 —  Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid ...

Home October 14, 2022
Home
The data, collected during the transition from intravenous (IV) to oral levosimendan in the open-label extension (OLE) of the HELP (Hemodynamic Evaluation of Levosimendan in PH-HFpEF) trial, were presented at the Heart Failure Society of America (HFSA) Scientific Sessions 2022
News | Heart Failure
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

October 13, 2022 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing, and ...

Home October 13, 2022
Home
the U.S. Patent and Trademark Office has issued to the University of Iowa Research Foundation ("UIRF") U.S. Patent No. 11,414,704 titled COMPOSITIONS AND METHODS FOR DETECTING PREDISPOSITION TO CARDIOVASCULAR DISEASE, which is exclusively licensed to the Company from UIRF
News | Heart Failure
Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

October 13, 2022 —  Cardio Diagnostics, Inc. , a pioneering precision cardiovascular testing company, announced that the ...

Home October 13, 2022
Home
Zach Williams wanted to be a cancer researcher, but quick success in another area refocused his research on cardiovascular science. He was awarded a National Institutes of Health grant to fund his research for two years. Image courtesy of Clayton Metz/Virginia Tech.
News | Heart Failure
Virginia Tech Graduate Student Earns NIH Support to Explore Promising Heart Finding

October 13, 2022 —  Zach Williams thought he’d become a cancer researcher when he joined Virginia Tech’s Translational ...

Home October 13, 2022
Home
Videos | TCT
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...

Home October 13, 2022
Home
The Delphi study results show Philips’ integrated echocardiography solution provides the tools required for baseline risk stratification and monitoring of cardio-oncology patients as recommended by the latest European Society of Cardiology (ESC) guidelines
News | Heart Failure
Panel of Experts Highlights Clinical and Operational Benefits of Philips’ Integrated Echocardiography Solution

October 12, 2022 —   Following the recent European Society of Cardiology (ESC) Congress in Barcelona, Spain last month, ...

Home October 12, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now